As Bavarian Nordic prepares to deliver on a large smallpox vaccine stockpiling contract with the U.S. government, the vaccine specialist is working to build out a new fill/finish manufacturing line at its headquarters in Denmark. Now, the company has new financing in the form of a €30 million loan from the European Investment Bank to apply toward the project.